Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc., trading under the ticker DNA on the New York Stock Exchange, completed its SPAC merger with Soaring Eagle Acquisition Corp in September 2021, with the SPAC sponsored by Eagle Equity Partners. The 10-Q filed on August 16, 2021, under accession number 0001193125-21-247705, was submitted ahead of that merger close and reflects Ginkgo's financial position as the transaction moved toward completion. The company operates in the synthetic biology sector, engineering custom organisms for applications across pharmaceuticals, agriculture, and industrial chemicals. The de-SPAC transaction, one of the larger biotechnology SPAC deals of 2021, brought the company to the public markets that year. Sign up for full data on SpacDesk to access complete filings, deal timelines, and sponsor intelligence on Ginkgo Bioworks and hundreds of other SPAC transactions.